REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB
The review of safety of monoclonal anti-ige-antibodies (xolair) - a new medication for the treatment of severe allergic bronchial asthma is presented. Local and system adverse events, originating after injection of medicament in clinical studies and following administration in patients are discussed...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Boek |
| Gepubliceerd in: |
"Paediatrician" Publishers LLC,
2008-10-01T00:00:00Z.
|
| Onderwerpen: | |
| Online toegang: | Connect to this object online. |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Search Result 1
REVIEW OF SAFETY AND TOLERANCE OF OMALIZUMAB
Gepubliceerd in 2008
Connect to this object online.
Boek